Current Neurogenic and Neuroprotective Strategies to Prevent and Treat Neurodegenerative and Neuropsychiatric Disorders

被引:0
|
作者
I. M. Carvalho
P. B. Coelho
P. C. Costa
C. S. Marques
R. S. Oliveira
D. C. Ferreira
机构
[1] University of Porto,Laboratory of Pharmaceutical Technology, Department of Drug Sciences, Faculty of Pharmacy
[2] University Fernando Pessoa,Department of Pharmaceutical Technology, Faculty of Health Sciences
来源
NeuroMolecular Medicine | 2015年 / 17卷
关键词
Neurogenesis; Neurotrophic factors; Neural stem cells; Neurodegenerative disorders; Retinoic acid; Curcuminoids;
D O I
暂无
中图分类号
学科分类号
摘要
The adult central nervous system is commonly known to have a very limited regenerative capacity. The presence of functional stem cells in the brain can therefore be seen as a paradox, since in other organs these are known to counterbalance cell loss derived from pathological conditions. This fact has therefore raised the possibility to stimulate neural stem cell differentiation and proliferation or survival by either stem cell replacement therapy or direct administration of neurotrophic factors or other proneurogenic molecules, which in turn has also originated regenerative medicine for the treatment of otherwise incurable neurodegenerative and neuropsychiatric disorders that take a huge toll on society. This may be facilitated by the fact that many of these disorders converge on similar pathophysiological pathways: excitotoxicity, oxidative stress, neuroinflammation, mitochondrial failure, excessive intracellular calcium and apoptosis. This review will therefore focus on the most promising achievements in promoting neuroprotection and neuroregeneration reported to date.
引用
收藏
页码:404 / 422
页数:18
相关论文
共 45 条
  • [1] Current Neurogenic and Neuroprotective Strategies to Prevent and Treat Neurodegenerative and Neuropsychiatric Disorders
    Carvalho, I. M.
    Coelho, P. B.
    Costa, P. C.
    Marques, C. S.
    Oliveira, R. S.
    Ferreira, D. C.
    NEUROMOLECULAR MEDICINE, 2015, 17 (04) : 404 - 422
  • [2] Putative neuroprotective agents in neuropsychiatric disorders
    Dodd, Seetal
    Maes, Michael
    Anderson, George
    Dean, Olivia M.
    Moylan, Steven
    Berk, Michael
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2013, 42 : 135 - 145
  • [3] Neurogenic regions in the adult: Relationship with the neuropsychiatric disorders
    Ramirez-Rodriguez, Gerardo
    del Carmen Silva-Lucero, Maria
    Gomez-Virgilio, Laura
    del Angel Ocana-Fernandez, Maria
    Ortiz-Lopez, Leonardo
    Torres-Perez, Mario O.
    Antonio Meraz-Rios, Marco
    SALUD MENTAL, 2013, 36 (03) : 201 - 210
  • [4] The Role of Lysophosphatidic Acid in Neuropsychiatric and Neurodegenerative Disorders
    Dedoni, Simona
    Camoglio, Chiara
    Siddi, Carlotta
    Scherma, Maria
    Fratta, Walter
    Fadda, Paola
    FUTURE PHARMACOLOGY, 2024, 4 (01): : 199 - 221
  • [5] Advanced strategies for enhancing the neuroprotective potential of curcumin: delivery systems and mechanistic insights in neurodegenerative disorders
    Panda, Pratikeswar
    Mohanty, Shreyashree
    Gouda, Sangita Ranee
    Baral, Tirtha Chandan
    Mohanty, Abhijit
    Nayak, Jyotirmay
    Mohapatra, Rajaram
    NUTRITIONAL NEUROSCIENCE, 2025,
  • [6] Small Molecules: Therapeutic Application in Neuropsychiatric and Neurodegenerative Disorders
    Schiavone, Stefania
    Trabace, Luigia
    MOLECULES, 2018, 23 (02):
  • [7] Benefits of the Neurogenic Potential of Melatonin for Treating Neurological and Neuropsychiatric Disorders
    Potes, Yaiza
    Cachan-Vega, Cristina
    Antuna, Eduardo
    Garcia-Gonzalez, Claudia
    Menendez-Coto, Nerea
    Boga, Jose Antonio
    Gutierrez-Rodriguez, Jose
    Bermudez, Manuel
    Sierra, Veronica
    Vega-Naredo, Ignacio
    Coto-Montes, Ana
    Caballero, Beatriz
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (05)
  • [8] Neuroprotective and neurotrophic actions of glucagon-like peptide-1: an emerging opportunity to treat neurodegenerative and cerebrovascular disorders
    Salcedo, Isidro
    Tweedie, David
    Li, Yazhou
    Greig, Nigel H.
    BRITISH JOURNAL OF PHARMACOLOGY, 2012, 166 (05) : 1586 - 1599
  • [9] Emerging evidence implicating a role for neurexins in neurodegenerative and neuropsychiatric disorders
    Cuttler, Katelyn
    Hassan, Maryam
    Carr, Jonathan
    Cloete, Ruben
    Bardien, Soraya
    OPEN BIOLOGY, 2021, 11 (10)
  • [10] Neuroprotective effects of antioxidants in the management of neurodegenerative disorders: A literature review
    Panahi, Yunes
    Rajaee, Seyyed Mahdi
    Johnston, Thomas P.
    Sahebkar, Amirhossein
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (03) : 2742 - 2748